Track Phreesia, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Phreesia, Inc. PHR Open Phreesia, Inc. in new tab

8.37 USD
EPS
-0.09
P/B
2.06
ROE
-1.87
Beta
0.72
Target Price
27.63 USD
Phreesia, Inc. logo

Phreesia, Inc.

🧾 Earnings Recap – Q4 2026

Phreesia, Inc. demonstrated strong financial performance in FY 2026, achieving key milestones including over $100 million in Adjusted EBITDA and positive GAAP net income for the first time, positioning the company for continued growth.

  • Surpassed $100 million in Adjusted EBITDA and over $50 million in free cash flow.
  • Delivered positive GAAP net income for the first time in the company's publicly traded history.
  • Progressing on strategic growth initiatives with the acquisition of AccessOne and the launch of ProviderConnect.
  • Emphasis on AI to enhance operational efficiency and margin expansion.
  • Navigating challenges in the healthcare market, particularly impacting longer visibility into spending commitments.
📅
Loading chart...
Key Metrics
Earnings dateMay 27, 2026
EPS-0.09
Book Value5.32
Price to Book2.06
Debt/Equity2.60
% Insiders4.828%
Growth
Revenue Growth0.46%
Estimates
Forward P/E7.29
Forward EPS1.51
Target Mean Price27.63

DCF Valuation

Tweak assumptions to recompute fair value for Phreesia, Inc. (PHR)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Phreesia, Inc. Logo Phreesia, Inc. Analysis (PHR)

United States Health Care Official Website Stock

Is Phreesia, Inc. a good investment? Phreesia, Inc. (PHR) is currently trading at 8.37 USD. Market analysts have a consensus price target of 27.63 USD. This suggests a potential upside from current levels.

Earnings Schedule: Phreesia, Inc. is expected to release its next earnings report on May 27, 2026. The market consensus estimate for Forward EPS is 1.51.

Investor FAQ

Does Phreesia, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Phreesia, Inc.?

Phreesia, Inc. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be May 27, 2026. The company currently has a trailing EPS of -0.09.

Company Profile

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers an appointment scheduling system for online appointments, reminders, and referral tracking and management; registration solutions to automate patient self-registration; revenue cycle solutions that provide insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network solutions to deliver clinically relevant content to patients. It deploys its platform in a range of modalities, including Phreesia Mobile, a patients' mobile device; PhreesiaPads, a self-service intake tablets; Phreesia Dashboard, a web-based dashboard for healthcare services clients; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare services clients, including single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies, as well as government entities and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.

Exchange Ticker
NYQ (United States) PHR
LSE (United Kingdom) 0A23.L
FRA (Germany) 19P.F

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion